natgillin/translations-raw huggingface dataset:
It is necessary to update the technical specifications of the Schengen consultation network to ensure that they reflect these changes.
Tehnične specifikacije Schengenske posvetovalne mreže je treba posodobiti, tako da bodo te spremembe upoštevane.
In accordance with Articles 1 and 2 of the Protocol on the position of Denmark, annexed to the Treaty on European Union and to the Treaty establishing the European Community, Denmark is not taking part in the adoption of this Decision and is not bound by it or subject to its application.
V skladu s členoma 1 in 2 Protokola o stališču Danske, ki je priložen k Pogodbi o Evropski uniji in Pogodbi o ustanovitvi Evropske skupnosti, Danska ne sodeluje pri sprejetju te odločbe, ki zato zanjo ni zavezujoča in se v njej ne uporablja.
Given that this Decision builds upon the Schengen acquis under the provisions of Title IV of Part Three of the Treaty establishing the European Community, Denmark is to decide, in accordance with Article 5 of the said Protocol, within a period of six months after the adoption of this Decision whether it will implement it in its national law.
Ker ta odločba nadgrajuje schengenski pravni red v skladu z določbami naslova IV tretjega dela Pogodbe o ustanovitvi Evropske skupnosti, se Danska v skladu s členom 5 navedenega protokola v šestih mesecih od sprejetja te odločbe odloči, ali bo to odločbo prenesla v svoje notranje pravo.
As regards Iceland and Norway, this Decision constitutes a development of provisions of the Schengen acquis within the meaning of the Agreement concluded by the Council of the European Union and the Republic of Iceland and the Kingdom of Norway concerning the latters’ association with the implementation, application and development of the Schengen acquis [2], which fall within the area referred to in Article 1, point A of Council Decision 1999/437/EC [3] on certain arrangements for the application of that Agreement.
Ta odločba predstavlja za Islandijo in Norveško nadaljnji razvoj določb schengenskega pravnega reda v smislu Sporazuma med Svetom Evropske unije in Republiko Islandijo ter Kraljevino Norveško o pridružitvi obeh k izvajanju, uporabi in razvoju schengenskega pravnega reda [2], ki sodijo na področje iz točke A člena 1 Sklepa Sveta 1999/437/ES [3] o nekaterih izvedbenih predpisih za uporabo navedenega sporazuma.
As regards Switzerland, this Decision constitutes a development of provisions of the Schengen acquis within the meaning of the Agreement between the European Union, the European Community and the Swiss Confederation concerning the association of the Swiss Confederation with the implementation, application and development of the Schengen acquis [4], which fall within the area referred to in Article 1, point A of Decision 1999/437/EC read in conjunction with Article 3 of Council Decision 2008/146/EC [5] on the conclusion, on behalf of the European Community, of that Agreement.
Ta odločba predstavlja za Švico nadaljnji razvoj določb schengenskega pravnega reda v smislu Sporazuma med Evropsko unijo, Evropsko skupnostjo in Švicarsko konfederacijo o pridružitvi Švicarske konfederacije k izvajanju, uporabi in razvoju schengenskega pravnega reda [4], ki sodijo na področje iz točke A člena 1 Sklepa Sveta 1999/437/ES [5], v povezavi s členom 3 Sklepa Sveta 2008/146/ES o sklenitvi tega sporazuma v imenu Evropske skupnosti.
As regards Liechtenstein, this Decision constitutes a development of provisions of the Schengen acquis within the meaning of the Protocol between the European Union, the European Community, the Swiss Confederation and the Principality of Liechtenstein on the accession of the Principality of Liechtenstein to the Agreement between the European Union, the European Community and the Swiss Confederation on the Swiss Confederation’s association with the implementation, application and development of the Schengen acquis, which fall within the area referred to in Article 1, point A of Decision 1999/437/EC read in conjunction with Article 3 of Council Decision 2008/261/EC [6] on the signature, on behalf of the European Community, and on the provisional application of certain provisions of that Protocol.
Ta odločba predstavlja za Lihtenštajn nadaljnji razvoj določb schengenskega pravnega reda v smislu Protokola med Evropsko unijo, Evropsko skupnostjo, Švicarsko konfederacijo in Kneževino Lihtenštajn o pristopu Kneževine Lihtenštajn k Sporazumu med Evropsko unijo, Evropsko skupnostjo in Švicarsko konfederacijo o pridružitvi Švicarske konfederacije k izvajanju, uporabi in razvoju schengenskega pravnega reda, ki sodijo na področje iz točke A člena 1 Sklepa Sveta 1999/437/ES v povezavi s členom 3 Sklepa Sveta 2008/261/ES [6] o podpisu v imenu Evropske skupnosti ter o začasni uporabi nekaterih določb tega protokola.
This Decision constitutes a development of provisions of the Schengen acquis in which the United Kingdom does not take part, in accordance with Council Decision 2000/365/EC of 29 May 2000 concerning the request of the United Kingdom of Great Britain and Northern Ireland to take part in some of the provisions of the Schengen acquis [7]; the United Kingdom is therefore not taking part in its adoption and is not bound by it or subject to its application.
Ta odločba predstavlja razvoj določb schengenskega pravnega reda, pri katerem Združeno kraljestvo ne sodeluje v skladu s Sklepom Sveta 2000/365/ES z dne 29. maja 2000 o prošnji Združenega kraljestva Velike Britanije in Severne Irske za sodelovanje pri izvajanju nekaterih določb schengenskega pravnega reda [7]; Združeno kraljestvo torej ne sodeluje pri sprejetju tega akta, ki zanj ni zavezujoč in se v njem ne uporablja.
This Decision constitutes a development of provisions of the Schengen acquis in which Ireland does not take part, in accordance with Council Decision 2002/192/EC of 28 February 2002 concerning Ireland’s request to take part in some of the provisions of the Schengen acquis [8]; Ireland is therefore not taking part in its adoption and is not bound by it or subject to its application.
Ta odločba predstavlja razvoj določb schengenskega pravnega reda, pri katerem Irska ne sodeluje v skladu s Sklepom Sveta 2002/192/ES z dne 28. februarja 2002 o prošnji Irske, da sodeluje pri izvajanju nekaterih določb schengenskega pravnega reda [8]. Irska torej ne sodeluje pri sprejetju tega akta, ki zanjo ni zavezujoč in se v njej ne uporablja.
As regards Cyprus, this Decision constitutes an act building on the Schengen acquis or otherwise related to it within the meaning of Article 3(2) of the 2003 Act of Accession.
Ta odločba predstavlja za Ciper akt, ki temelji na schengenskem pravnem redu ali je z njim kako drugače povezan v smislu člena 3(2) Akta o pristopu iz leta 2003.
Part 1 of the Schengen consultation network (technical specifications) is amended as shown in Annex I.
Del 1 Schengenske posvetovalne mreže (tehnične specifikacije) se spremeni v skladu s Prilogo I.
Part 2 of the Schengen consultation network (technical specifications) is amended as shown in Annex II.
Del 2 Schengenske posvetovalne mreže (tehnične specifikacije) se spremeni v skladu s Prilogo II.
This Decision shall apply from 1 February 2009.
Ta odločba se uporablja od 1. februarja 2009.
OJ L 53, 27.2.2008, p. 52.
UL L 53, 27.2.2008. str. 52.
OJ L 53, 27.2.2008, p. 1.
UL L 53, 27.2.2008. str. 1.
Part 1 of the Schengen consultation network (technical specifications) is hereby amended as follows:
Del 1 Schengenske posvetovalne mreže (tehnične specifikacije) se spremeni:
As a matter of principle Vision is designed as a system running 24 hours a day, seven days a week.
As a matter of principle Vision is designed as a system running 24hours a day, seven days a week.
They must resend messages which have not been delivered, but not overload other partner systems by, for example, unnecessary repetition of messages which are thought to have been lost.’;
They must resend messages which have not been delivered, but not overload other partner systems by, for example, unnecessary repetition of messages which are thought to have been lost.“;
point 1.2.1 shall be replaced by the following:
točka 1.2.1 se nadomesti z naslednjim:
“retransmitting” means sending again the same message, usually subject to retransmission parameters of the MTA (e.g. sendmail, MS-Exchange, Lotus Notes).
‚retransmitting‘ means sending again the same message, usually subject to retransmission parameters of the MTA (e.g. sendmail, MS-Exchange, Lotus Notes).
“resending as a new message” means that a new message with the same content is prepared.
‚resending as a new message‘ means that a new message with the same content is prepared.
Part 2 of the Schengen consultation network (technical specifications) is hereby amended as follows:
Del 2 Schengenske posvetovalne mreže (tehnične specifikacije) se spremeni:
in point 2.1.4, Heading No 026 shall be replaced by the following:
v točki 2.1.4 se naslov št. 026 nadomesti z naslednjim:
long-stay visas valid concurrently as short-stay visas’;
long-stay visas valid concurrently as short-stay visas“;
in points 2.1.4 (Form A), 2.1.6 (Form C), 2.1.7 (Form F), the content of row 026 in the fifth column of the table (‘Examples/Comments’) shall be replaced by the following:
v točkah 2.1.4 (Form A), 2.1.6 (Form C), 2.1.7 (Form F) se vsebina vrstice 026 v peti koloni tabele („Examples/Comments“) nadomesti z naslednjim:
short -stay visas
short-stay visas
establishing of a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products
o vzpostavitvi seznama rastlinskih snovi, pripravkov in kombinacij iz njih za uporabo v tradicionalnih zdravilih rastlinskega izvora
(notified under document number C(2008) 6933)
(notificirano pod dokumentarno številko C(2008) 6933)
Having regard to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use [1], and in particular Article 16(f) thereof,
ob upoštevanju Direktive 2001/83/ES Evropskega parlamenta in Sveta z dne 6. novembra 2001 o zakoniku Skupnosti o zdravilih za uporabo v humani medicini [1] in zlasti člena 16(f) Direktive,
Having regard to the opinions of the European Medicines Agency, formulated on 7 September 2007 by the Committee for Herbal Medicinal Products,
ob upoštevanju mnenj Evropske agencije za zdravila, ki jih je 7. septembra 2007 oblikoval Odbor za zdravila rastlinskega izvora,
Foeniculum vulgare Miller subsp. vulgare var. vulgare and Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung comply with the requirements set out in Directive 2001/83/EC.
Foeniculum vulgare Miller subsp. vulgare var. vulgare in Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung sta v skladu z zahtevami Direktive 2001/83/ES.
Foeniculum vulgare Miller subsp. vulgare var. vulgare and Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung can be considered as herbal substances, herbal preparations and/or combinations thereof.
Foeniculum vulgare Miller subsp. vulgare var. vulgare in Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung se lahko obravnavata kot rastlinske snovi, pripravki in/ali kombinacije iz njih.
It is therefore appropriate to establish a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products including the entry of Foeniculum vulgare Miller subsp. vulgare var. vulgare and the entry of Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung.
Zato je primerno vzpostaviti seznam rastlinskih snovi, pripravkov in kombinacij iz njih za uporabo v tradicionalnih zdravilih rastlinskega izvora, ki vključuje vnosa Foeniculum vulgare Miller subsp. vulgare var. vulgare in Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung.
The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Medicinal Products for Human Use,
Ukrepi, predvideni s to odločbo, so v skladu z mnenjem Stalnega odbora za zdravila za ljudi –
A list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products is established in Annex I including the entry of Foeniculum vulgare Miller subsp. vulgare var. vulgare and the entry of Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung.
Seznam rastlinskih snovi, pripravkov in kombinacij iz njih za uporabo v tradicionalnih zdravilih rastlinskega izvora, ki vključuje vnosa Foeniculum vulgare Miller subsp. vulgare var. vulgare in Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung, je določen v Prilogi I.
The indications, the specified strengths and the posology, the route of administration and any other information necessary for the safe use as a traditional medicinal product relevant for Foeniculum vulgare Miller subsp. vulgare var. vulgare and Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung are set out in Annex II to this decision.
Indikacije, jakost, odmerjanje, pot uporabe in druge informacije, potrebne za varno uporabo kot tradicionalno zdravilo, ustrezni za Foeniculum vulgare Miller subsp. vulgare var. vulgare in Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung, so navedeni v Prilogi II k tej odločbi.
List of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products established in accordance with Article 16f of Directive 2001/83/EC as amended by Directive 2004/24/EC
Seznam rastlinskih snovi, pripravkov in kombinacij iz njih za uporabo v tradicionalnih zdravilih rastlinskega izvora, vzpostavljen v skladu s členom 16(f) Direktive 2001/83/ES, kakor je bila spremenjena z Direktivo 2004/24/ES
Foeniculum vulgare Miller subsp. vulgare var. vulgare (bitter fennel fruit)
Foeniculum vulgare Miller subsp. vulgare var. vulgare (grenki navadni komarček, plod)
Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (sweet fennel fruit)
Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (sladki navadni komarček, plod)
COMMUNITY LIST ENTRY ON FOENICULUM VULGARE MILLER SUBSP.
VPIS V SEZNAM SKUPNOSTI FOENICULUM VULGARE MILLER SUBSP.
Scientific name of the plant
Znanstveno ime rastline
Botanical family
Botanična družina
Herbal substance
Rastlinska snov
Fennel, bitter
Grenki navadni komarček
Common name in all EU official languages of herbal substance
Splošno ime rastlinske snovi v vseh uradnih jezikih EU
Herbal preparation(s)
Pripravek rastlinskega izvora
Fennel, bitter, dried comminuted [1] fruit.European Pharmacopoeia monograph reference
Posušen, zdrobljen [1] plod grenkega navadnega komarčka.Sklic na monografijo Evropske farmakopeje
Traditional herbal medicinal product for symptomatic treatment of mild, spasmodic gastro-intestinal complaints including bloating and flatulence.
Tradicionalno zdravilo rastlinskega izvora za simptomatsko zdravljenje blagih prebavnih težav s krči, vključno z napenjanjem in vetrovi.
Traditional herbal medicinal product for symptomatic treatment of minor spasm associated with menstrual periods.
Tradicionalno zdravilo rastlinskega izvora za simptomatsko zdravljenje blažjih krčev, povezanih z menstruacijo.
Traditional herbal medicinal product used as an expectorant in cough associated with cold.
Tradicionalno zdravilo rastlinskega izvora, ki se uporablja kot ekspektorans (zdravilo za lažje izkašljevanje) pri kašlju, povezanem s prehladom.
The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use.
Izdelek je tradicionalno zdravilo rastlinskega izvora, namenjeno za uporabo pri navedenih indikacijah izključno na podlagi dolgotrajnih izkušenj.
European, Chinese.
Evropska, kitajska.
Specified strength
Jakost
Please see ‘Specified posology’.
Glejte „Odmerjanje“.
Specified posology
Odmerjanje
Single dose
Enkratni odmerek
1,5 to 2,5 g of (freshly [2]) comminuted fennel fruits with 0,25 l of boiling water (brew for 15 minutes) three times daily as a herbal tea.
1,5 do 2,5 g (sveže [2]) zdrobljenih plodov navadnega komarčka z 0,25 l vrele vode (pustite stati 15 minut) trikrat dnevno kot zdravilni čaj.
Adolescents over 12 years of age, indication (a)
Mladostniki nad 12 let, Indikacija (a)
Adult dose
Odmerek za odrasle
Children between four and 12 years of age, indication (a)
Otroci, stari od 4 do 12 let, Indikacija (a)
Average daily dose
Povprečni dnevni odmerek
3-5 g of (freshly) comminuted fruits as a herbal tea, in three divided doses, for short-term use in mild transitory symptoms only (less than one week).
3–5 g (sveže) zdrobljenih plodov kot zdravilni čaj, v treh razdeljenih odmerkih, za kratkotrajno uporabo samo pri blagih prehodnih simptomih (manj kot en teden).
The use in children under four years of age is not recommended (see section ‘Special warnings and precautions for use’).
Uporaba pri otrocih, mlajših od 4 let, ni priporočljiva (glejte poglavje „Posebna opozorila in previdnostni ukrepi“).
Route of administration
Pot uporabe zdravila
Duration of use or any restrictions on the duration of use
Trajanje uporabe oziroma vse omejitve trajanja uporabe
Not to be taken for more than two weeks.
Zdravila se ne sme jemati več kot 2 tedna.
For short-term use in mild transitory symptoms only (less than one week).
Samo za kratkotrajno uporabo pri blagih prehodnih simptomih (manj kot en teden).
If the symptoms persist during the use of the medicinal product, a doctor or a qualified health-care practitioner should be consulted.
Če simptomi med uporabo zdravila ne popustijo, se je treba posvetovati z zdravnikom ali usposobljenim zdravstvenim delavcem.
Any other information necessary for the safe use
Druge informacije, potrebne za varno uporabo
Hypersensitivity to the active substance or to Apiaceae (Umbelliferae) (aniseed, caraway, celery, coriander and dill) or to anethole.
Preobčutljivost na zdravilno učinkovino ali na Apiaceae (Umbelliferae) (janež, kumina, zelena, koriander in koper) ali na anetol.
Special warnings and precautions for use
Posebna opozorila in previdnostni ukrepi
The use in children under four years of age is not recommended due to the lack of adequate data and a paediatrician’s advice should be sought.
Zaradi pomanjkanja ustreznih podatkov uporaba pri otrocih, mlajših od 4 let, ni priporočljiva. Posvetujte se s pediatrom.
Interactions with other medicinal products and other forms of interaction
Medsebojno delovanje z drugimi zdravili in druge oblike interakcij
None reported.
Ni poročil.
Pregnancy and lactation
Nosečnost in dojenje
There are no data from the use of fennel fruit in pregnant patients.
Ni podatkov o uporabi ploda navadnega komarčka pri nosečnicah.
It is unknown if fennel constituents are excreted in human breast milk.
Ni znano, ali se sestavine navadnega komarčka izločajo v materino mleko.
In the absence of sufficient data, the use during pregnancy and lactation is not recommended.
Ker ni zadostnih podatkov, uporaba med nosečnostjo in dojenjem ni priporočljiva.
Effects on ability to drive and use machines
Vpliv na sposobnost vožnje in upravljanja s stroji
No studies on the effect on the ability to drive and use machines have been performed.
Študije o vplivu na sposobnost vožnje in upravljanja s stroji niso bile izvedene.
Allergic reactions to fennel, affecting the skin or the respiratory system may occur.
Možne so preobčutljivostne reakcije na komarček, ki prizadenejo kožo ali dihalni sistem.
The frequency is not known.
Pogostost ni znana.
If other adverse reactions not mentioned above occur, a doctor or a qualified health-care practitioner should be consulted.
Če se pojavijo drugi neželeni učinki, ki niso navedeni zgoraj, se je treba posvetovati z zdravnikom ali usposobljenim zdravstvenim delavcem.
No case of overdose has been reported.
Ni poročil o primerih prevelikega odmerjanja.
Pharmaceutical particulars (if necessary)
Farmacevtski podatki (če so potrebni)
Pharmacological effects or efficacy plausible on the basis of long-standing use and experience (if necessary for the safe use of the product)
Verjetni farmakološki učinki ali učinkovitost, ugotovljeni na podlagi dolgotrajne uporabe in izkušenj (če je potrebno za varno uporabo zdravila)
Fennel, sweet
Sladki navadni komarček
Fennel, sweet, dried comminuted [3] or powdered fruit.European Pharmacopoeia monograph reference
Posušen, zdrobljen [3] ali uprašen plod sladkega navadnega komarčka.Sklic na monografijo Evropske farmakopeje
1,5 to 2,5 g of (freshly [4]) comminuted fennel fruits with 0,25 l of boiling water (brew for 15 minutes) three times daily as a herbal tea.
1,5 do 2,5 g (sveže [4]) zdrobljenih plodov navadnega komarčka z 0,25 l vrele vode (pustite stati 15 minut) trikrat dnevno kot zdravilni čaj.
Fennel powder: 400 mg three times a day (with a maximum of 2 g daily).
Navadni komarček v prahu: 400 mg trikrat dnevno (največja količina ne sme preseči 2 g dnevno).
Allergic reactions to fennel, affecting the skin or the respiratory system, may occur.
Možne so preobčutljivostne reakcije na komarček, ki prizadenejo kožo ali dihalni sistem.
‘Comminuted fruit’ is intended to cover also ‘crushed fruit’.
„Zdrobljen plod“ pomeni tudi „strt plod“.
For commercial preparation of comminuted fennel fruits the applicant must carry out appropriate stability testing related to the content of essential oil components.
Za komercialni pripravek zdrobljenih plodov navadnega komarčka mora predlagatelj izvesti ustrezno preskušanje stabilnosti glede vsebnosti komponent eteričnih olj.
For commercial preparation of comminuted or powdered fennel fruits the applicant must carry out appropriate stability testing related to the content of essential oil components.
Za komercialni pripravek zdrobljenih ali uprašenih plodov navadnega komarčka mora predlagatelj izvesti ustrezno preskušanje stabilnosti glede vsebnosti komponent eteričnih olj.
VULGARE, FRUCTUS
VULGARE
as regards a Community financial contribution for the year 2009 to certain Community reference laboratories in the feed and food control area
o finančnem prispevku Skupnosti za leto 2009 nekaterim referenčnim laboratorijem Skupnosti na področju nadzora krme in živil
(notified under document number C(2008) 7283)
(notificirano pod dokumentarno številko C(2008) 7283)
(Only the texts in Spanish, Danish, German, English, French, Italian, Dutch and Swedish are authentic)
(Besedilo v angleškem, danskem, francoskem, italijanskem, nemškem, nizozemskem, španskem in švedskem jeziku je edino verodostojno)
Having regard to Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules [1], and in particular Article 32(7) thereof,
ob upoštevanju Uredbe (ES) št. 882/2004 Evropskega parlamenta in Sveta z dne 29. aprila 2004 o izvajanju uradnega nadzora za zagotovitev preverjanja skladnosti z zakonodajo o krmi in živilih ter s pravili o zdravstvenem varstvu živali in zaščiti živali [1] ter zlasti člena 32(7) Uredbe,
Commission Regulation (EC) No 1754/2006 of 28 November 2006 laying down detailed rules for the granting of Community financial assistance to Community reference laboratories for feed and food and the animal health sector [3] provides that the financial contribution from the Community is to be granted if the approved work programmes are efficiently carried out and that the beneficiaries supply all the necessary information within certain time limits.
Uredba Komisije (ES) št. 1754/2006 z dne 28. novembra 2006 o določitvi pravil za dodeljevanje finančne pomoči Skupnosti referenčnim laboratorijem Skupnosti za krmo, živila in sektor za zdravstveno varstvo in zaščito živali [3] določa, da se finančna pomoč Skupnosti dodeli, če se odobreni delovni programi učinkovito izvajajo in upravičenci v določenih rokih sporočijo vse potrebne informacije.
In accordance with Article 2 of Regulation (EC) No 1754/2006 the relationship between the Commission and each Community reference laboratories is laid down in a partnership agreement which is supported by a multiannual work programme.
V skladu s členom 2 Uredbe (ES) št. 1754/2006 razmerje med Komisijo in posameznimi referenčnimi laboratoriji Skupnosti določa sporazum o partnerstvu, ki ga podpira večletni delovni program.